Delivery Order SPE2DB24D9250-SPE2DB25FJVLB
Award Date 9/25/25
Potential Completion Date 10/17/25
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,375.53 by the Defense Logistics Agency for Nuplazid 34 mg capsules (30-count units). The contract, issued on June 3, 2025, with an ultimate completion date of June 25, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,458.51 on July 14, 2025, for the supply of Nuplazid 34 mg capsules (30-count packages) under contract 4568809623. The award utilizes firm fixed-price pricing with no set-aside designation and is scheduled for completion by August 4, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $10,375.53 for 30 Nuplazid 34 mg capsules by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a continuation of pharmaceutical supply services to the Department of Defense healthcare system. The contract carries...
- The Defense Logistics Agency awarded a $10,375.53 delivery order to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Nuplazid 34 mg capsules in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, carries no set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this requirement through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUPLAZID 34 mg capsules (30-count units). This firm fixed-price delivery order, issued on August 7, 2025, with completion targeted for August 28, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,917.02 contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a period of performance through April 1, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 20, 2025. The contract covers the supply of Nuplazid 34 mg capsules in quantities of 30, with a firm fixed-price structure and an ultimate completion date of September 11, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an...
- The Defense Logistics Agency awarded a $3,458.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in quantities of 30. The award was issued on September 11, 2025, with an ultimate completion date of October 2, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $20,751.06 to DMS Pharmaceutical Group Inc. for 30 capsules of Nuplazid 34 mg on August 18, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed in Park Ridge, Illinois. Nuplazid (pimavanserin) is an atypical antipsychotic used to treat psychosis associated with Parkinson's disease, and this order...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,375.53 contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through February 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, allowing the agency to issue delivery...